Company Profiles

driven by the PitchBook Platform

Neotropix

Description

Developer of deliverable oncolytic viruses for the treatment of cancer. The company develops viruses for oncology applications and offers NTX010, a cancer fighting virus.

2003

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$1.4M

Latest Deal Amount

$17.4M

Total Amount Raised

Description

Developer of deliverable oncolytic viruses for the treatment of cancer. The company develops viruses for oncology applications and offers NTX010, a cancer fighting virus.

Website:

www.neotropix.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

351 Phoenixville Pike Malvern, PA 19355United States +1 (617) 460-1200
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Neotropix's full profile, request a free trial.

    Neotropix Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Neotropix Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Neotropix Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Quaker PartnersVenture CapitalMinority000 0000000 0000
    The Aurora FundsVenture CapitalMinority000 0000000 0000
    VIMAC VenturesVenture CapitalMinority000 0000000 0000
    Quaker Partners Venture Capital
    The Aurora Funds Venture Capital
    VIMAC Ventures Venture Capital

    Neotropix Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Christopher Kroeger MDThe Aurora FundsPartner000 0000
    Sena Biswas Ph.DVIMAC VenturesManaging Director, Life Sciences000 0000
    Christopher Kroeger MD Partner The Aurora Funds
    Sena Biswas Ph.D Managing Director, Life Sciences VIMAC Ventures
    Request full access to PitchBook